Eagle Pharmaceuticals Announces “Save the Date” for 2016 Investor Day
September 27 2016 - 3:30PM
Business Wire
Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”)
(NASDAQ:EGRX) today announced that Scott Tarriff, President and
Chief Executive Officer, David Riggs, Chief Financial Officer, and
other members of Eagle's senior management team will host an
Investor Day in New York City on November 11, 2016.
The event will focus on the Company's growth initiatives,
R&D pipeline and financial outlook. It will provide additional
insight on Ryanodex® for Exertional Heat Stroke and Methamphetamine
and Ecstasy Intoxication, recent product launches and new growth
opportunities.
Event: Eagle Pharmaceuticals Investor DayDate:
November 11, 2016Time: 8:00 a.m. ET to 11:30 a.m. ET
(registration and breakfast begin at 7:00 a.m. ET).Location:
The Pierre 2 East 61st Street, New York City
Institutional investors and analysts who wish to register can
RSVP to Lisa Wilson, Investor Relations for Eagle Pharmaceuticals,
either via telephone at 1-212-452-2793 or e-mail at
lwilson@insitecony.com.
An audio webcast of the presentation will be available by
visiting the Investor Relations section of Eagle Pharmaceuticals
web site at www.eagleus.com. A replay of the presentation will be
available for 90 days.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on
developing and commercializing injectable products that address the
shortcomings, as identified by physicians, pharmacists and other
stakeholders, of existing commercially successful injectable
products. Eagle’s strategy is to utilize the FDA's 505(b)(2)
regulatory pathway. Additional information is available on the
company’s website at www.eagleus.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160927006682/en/
Investor Relations for Eagle Pharmaceuticals, Inc.In-Site
CommunicationsLisa Wilson, 212-452-2793
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Apr 2024 to May 2024
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From May 2023 to May 2024